Document Detail


The course of untreated Mycobacterium kansasii disease.
MedLine Citation:
PMID:  1124888     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Four patients with Mycobacterium kansaii pulmonary infection were followed without treatment for 10 to 14 years after diagnosis. Although spontaneous resolution of active disease occurred 5 years after diagnosis in one patient, slowly progressive disease in the absence of significant symptoms was documented in 3 patients during a 12-to-14-year follow-up period. Administration of antituberculous drugs resulted in rapid resolution of signs of active disease in these patients. These observations added to our limited knowledge of the natural history of M. kansasii disease.
Authors:
P B Francis; S J Jay; W G Johanson
Related Documents :
20002758 - Associated conditions and clinical significance of awake bruxism.
10436098 - Increased thromboxane biosynthesis is associated with poststroke dementia.
11117548 - The selective muscarinic m1 agonist af102b decreases levels of total abeta in cerebrosp...
8845698 - Quantified electroencephalographic correlates of relative frontal or parietal hypoperfu...
16461328 - Breakthrough fungemia caused by fluconazole-resistant candida albicans with decreased s...
21071108 - Availability of a newly devised ambulatory urodynamics monitoring system based on perso...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American review of respiratory disease     Volume:  111     ISSN:  0003-0805     ISO Abbreviation:  Am. Rev. Respir. Dis.     Publication Date:  1975 Apr 
Date Detail:
Created Date:  1975-07-07     Completed Date:  1975-07-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370523     Medline TA:  Am Rev Respir Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  477-87     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Ethambutol / therapeutic use
Female
Follow-Up Studies
Forced Expiratory Volume
Humans
Isoniazid / therapeutic use
Lung Diseases* / microbiology,  radiography
Male
Middle Aged
Mycobacterium / isolation & purification
Mycobacterium Infections* / microbiology,  radiography
Rifampin / therapeutic use
Vital Capacity
Chemical
Reg. No./Substance:
13292-46-1/Rifampin; 54-85-3/Isoniazid; 74-55-5/Ethambutol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Suppression of lymphocyte function by products derived from cigarette smoke.
Next Document:  Tension pleural effusion. A delayed complication of pneumothorax therapy in tuberculosis.